Safety, Tolerability and Efficacy Study of Doxycycline Foam for the Prevention of EGFRI Skin Toxicity in Cancer Patients
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability and efficacy of FDX104
Antibiotic Foam in the prevention of EGFRI skin toxicity in cancer patients receiving
Cetuximab or Panitumumab.